ATG-201
ATG-201 is a novel T-cell engager (TCE). ATG-201 exhibits CD19-dependent CD3 binding and activation properties, enabling the effective depletion of B cells. ATG-201 can be used to study B-cell malignancies and B-cell-related autoimmune diseases.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Species Reactivity
Human
Target
CD3 & CD19
Conjugated
Unconjugated
Anwendung
ELISA, FACS, Functional assay
Chemical Information
-
SMILES
[ATG-201]
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)